WHO ICTRP trial
A prospective, single-center, randomized controlled clinical study evaluating…
ChiCTR2500112800 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500112800 |
|---|---|
| Public title | A prospective, single-center, randomized controlled clinical study evaluating the efficacy and safety of hyperbaric oxygen therapy as an adjunctive treatment for chronic heart failure |
| Scientific title | A prospective, single-center, randomized controlled clinical study evaluating the efficacy and safety of hyperbaric oxygen therapy as an adjunctive treatment for chronic heart failure |
| Primary sponsor | Fujian Medical University Union Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Chronic cardiac failure |
| Interventions | Experimental group:Conventional heart failure drug treatment is based on the 'new four combination' (ARNI/ACEI/ARB, ß-blockers, MRA, SGLT2 inhibitors). Hyperbaric oxygen therapy;Control group:Conventional heart failure drug treatment is… |
| Registration date | Nov 19, 2025 |
| Target size | Experimental group:75;Control group:75 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: